MONITORING CAFFEINE IN HUMAN SALIVA USING A NEWLY DEVELOPED ELISA

被引:6
作者
Carvalho, Jose Joao [1 ]
Weller, Michael G. [1 ]
Panne, Ulrich [1 ,2 ]
Schneider, Rudolf J. [1 ]
机构
[1] BAM Fed Inst Mat Res & Testing, D-12489 Berlin, Germany
[2] Univ Berlin, Dept Chem, Berlin, Germany
关键词
Caffeine; Cytochrome P450 CYP1A2; Enzyme-linked immunosorbent assay; LC-MS/MS; Liver function tests; Saliva; MULTIPLIED IMMUNOASSAY TECHNIQUE; CLINICAL-CHEMISTRY SYSTEM; LIVER-FUNCTION; CHROMATOGRAPHIC DETERMINATION; COGNITIVE PERFORMANCE; METHOTREXATE ASSAYS; HUMAN PLASMA; CLEARANCE; CYP1A2; EMIT;
D O I
10.1080/00032719.2012.696226
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Caffeine is a useful indicator to quickly assess liver function. High-throughput tests are needed for single-point caffeine measurements, with low cross-reactivity toward its major metabolite, paraxanthine. A newly developed ELISA was compared with an LC-MS/MS reference method, using 60 saliva samples from 10 individuals, before and after caffeine intake. Bland-Altman plot, Student t-test and F-test were used to compare the two methods. Proteins were precipitated using organic solvent and the caffeine recoveries compared with those obtained using sample microfiltration. The antibody, with a low cross-reactivity toward paraxanthine (0.08%), allows quantification of caffeine in saliva samples from 2.5 mu g/L to 125 mu g/L with high precision and the ELISA shows comparable results to those obtained by LC-MS/MS. A one-step protein precipitation using an organic solvent provides comparable results to a more costly and time-consuming microfiltration pre-treatment of samples. The new ELISA is a fit-for-purpose method to accurately and precisely determine caffeine in saliva samples.
引用
收藏
页码:2549 / 2561
页数:13
相关论文
共 41 条
[1]   Monitoring carbamazepine in surface and wastewaters by an immunoassay based on a monoclonal antibody [J].
Bahlmann, Arnold ;
Weller, Michael G. ;
Panne, Ulrich ;
Schneider, Rudolf J. .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2009, 395 (06) :1809-1820
[2]   Caffeine in saliva after peroral intake: Early sample collection as a possible source of error [J].
Biederbick, W ;
Joseph, G ;
Rump, A ;
Theisohn, M ;
Klaus, W .
THERAPEUTIC DRUG MONITORING, 1997, 19 (05) :521-524
[3]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[4]   Caffeine levels in saliva: associations with psychosocial factors and behavioural effects [J].
Brice, C ;
Smith, A .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2001, 16 (07) :507-521
[5]   Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine [J].
Carrillo, JA ;
Christensen, M ;
Ramos, SI ;
Alm, C ;
Dahl, ML ;
Benítez, J ;
Bertilsson, L .
THERAPEUTIC DRUG MONITORING, 2000, 22 (04) :409-417
[6]   7-(5-Carboxypentyl)-1,3-dimethyl-xanthine monohydrate [J].
Carvalho, Jose Joao ;
Emmerling, Franziska ;
Schneider, Rudolf J. .
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 :O3718-U2211
[7]   A highly sensitive caffeine immunoassay based on a monoclonal antibody [J].
Carvalho, Jose Joao ;
Weller, Michael G. ;
Panne, Ulrich ;
Schneider, Rudolf J. .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2010, 396 (07) :2617-2628
[8]   Urinary caffeine after coffee consumption and heat dehydration [J].
Chambaz, A ;
Meirim, I ;
Décombaz, J .
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 2001, 22 (05) :366-372
[9]   Simultaneous determination of five HIV protease inhibitors nelfinavir, indinavir, ritonavir, saquinavir and amprenavir in human plasma by LC/MS/MS [J].
Chi, JD ;
Jayewardene, AL ;
Stone, JA ;
Motoya, T ;
Aweeka, FT .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 30 (03) :675-684
[10]  
COOK CE, 1976, J PHARMACOL EXP THER, V199, P679